Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NNFA In Brief: Biotherapies' Combicart

This article was originally published in The Tan Sheet

Executive Summary

Biotherapies' Combicart: Containing 375 mg Cartilade shark cartilage and 375 mg bovine cartilage shipping to health food stores, physician resellers and independent pharmacies, the company, formerly Cartilage Technologies, announces. The product will retail for about $65.95 for a 180-count bottle of caplets. Combicart "obviates the need for the consumer to make [the] difficult decision" between shark and bovine cartilage, Biotherapies says. The company also is introducing Fisol slow-release fish oil. The product, with enhanced "acceptability," has improved "absorption of essential fatty acids, thereby providing a...cost-effective approach in obtaining the health benefits" of fish oil supplementation, the company says. Combicart will retail for about $29.95 for 90 caplets. Ads are planned for consumer "health-oriented" magazines such as Let's Live and Delicious...

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts